VR1 Corp — Form D/A
VR1 Corp of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2013-12-19. The offering totals $150K, of which $150K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-12-19
- Form: D/A
- Accession: 0001561045-13-000004
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $150K
- Amount sold: $150K
- Investors: 7
- Date of first sale: 2013-10-18
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-205335
Issuer
- Name: VR1 Corp
- CIK: 0001561045
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 68 EAST 131ST STREET, SUITE 307, NEW YORK, NY, 10037
- Phone: 212-368-2500
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Anjan Chatterjee | Director | New York, NY |
| Anjan Chatterjee | Executive Officer | New York, NY |
| Michele Harris | Director | New York, NY |
| Michele Harris | Executive Officer | New York, NY |
Other filings by this issuer (5)
More